Softgels: The Missed Opportunity for Superior Bioavailability and Modulated Drug Release

Monday, October 21, 2024

3:30 PM – 4:30 PM MT

Location:360 Stage #2, Exhibit Hall

Sponsored By

Partner Presentation Speaker(s)

Karunakar (Karu) Sukuru, R.Ph., PhD

Global VP Rx- Product Development, Pharma and Consumer Health
Catalent
Somerset, New Jersey

Description: Softgels offer significant benefits in bioavailability and modulated drug release, making them a strategic choice in pharmaceutical development. This presentation addresses several myths about softgels and lipid based formulations (LBFs), highlighting their advantages over other bioavailability enhancing technologies. By exploring recent innovations and manufacturing benefits, you'll learn how softgels can optimize drug delivery and provide a competitive edge in pharmaceutical development.

Learning Objectives:

Discuss new innovations in softgels.
Address myths and identify benefits of LBFs in softgels over other bioavailability-enhancing technologies.
Understand the manufacturing perspectives and limitations of various bioavailability enhancing technologies.